RASILEZ

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, United Kingdom, South Africa

Active ingredients

The drug RASILEZ contains one active pharmaceutical ingredient (API):

1 Aliskiren
UNII C8A0P8G029 - ALISKIREN HEMIFUMARATE

Aliskiren is an orally active, non-peptide, potent and selective direct inhibitor of human renin. By inhibiting the enzyme renin, aliskiren inhibits the RAAS at the point of activation, blocking the conversion of angiotensinogen to angiotensin I and decreasing levels of angiotensin I and angiotensin II.

Read about Aliskiren

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RASILEZ Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C09XA02 Aliskiren C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09X Other agents acting on the renin-angiotensin system → C09XA Renin-inhibitors
Discover more medicines within C09XA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02302063, 02302071
Country: EE Ravimiamet Identifier(s): 1307023, 1307034, 1307045, 1307056, 1307067, 1307078, 1307089, 1307090, 1307102, 1307113, 1307124, 1307135, 1307146, 1307157, 1307168, 1307179, 1307180, 1307191, 1307203, 1307214
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 07405022, 07405032
Country: FR Base de données publique des médicaments Identifier(s): 61195604, 61280428
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 119610, 119618, 175904, 178849, 180663, 186092, 186094, 375325, 375328
Country: HK Department of Health Drug Office Identifier(s): 60309, 60310
Country: IE Health Products Regulatory Authority Identifier(s): 68210, 68211, 68250, 68255, 68280, 68281
Country: IT Agenzia del Farmaco Identifier(s): 038243010, 038243022, 038243034, 038243046, 038243059, 038243061, 038243073, 038243085, 038243097, 038243109, 038243111, 038243123, 038243135, 038243147, 038243150, 038243162, 038243174, 038243186, 038243198, 038243200, 038243212, 038243224, 038243236, 038243248, 038243251, 038243263, 038243275, 038243287, 038243299, 038243301, 038243313, 038243325, 038243337, 038243349, 038243352, 038243364, 038243376, 038243388, 038243390, 038243402
Country: JP 医薬品医療機器総合機構 Identifier(s): 2149047F1028
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1030623, 1030624, 1030625, 1030626, 1030627, 1030628, 1030629, 1030630, 1030631, 1030632, 1030633, 1030634, 1030635, 1030636, 1030637, 1030638, 1030639, 1030640, 1030641, 1030642, 1056696, 1056697, 1056698, 1056699, 1056700, 1056701, 1056702, 1056703, 1056704, 1056705, 1056706, 1056707, 1056708, 1056709, 1056710, 1056711, 1056712, 1056713, 1056714, 1056715
Country: NL Z-Index G-Standaard, PRK Identifier(s): 85065, 85073
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100147757, 100178657
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W52241001, W52241002, W52241003, W52241004, W52241005, W52241006, W52241007, W52241008, W52241009, W52241010, W52242001, W52242002, W52242003, W52242004, W52242005, W52242006, W52242007, W52242008, W52242009, W52242010
Country: ZA Health Products Regulatory Authority Identifier(s): 41/7.1.3/0971, 41/7.1.3/0972

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.